PT Enseval Putera Megatrading Tbk. (EPMT.JK)
IDR 2320.0
(-1.28%)
IDR 2320.0
(-1.28%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3658.01 Billion IDR | 12.05% |
| 2022 | 3264.73 Billion IDR | 13.24% |
| 2021 | 2882.99 Billion IDR | 8.7% |
| 2020 | 2652.27 Billion IDR | 2.97% |
| 2019 | 2575.65 Billion IDR | 1.6% |
| 2018 | 2535.1 Billion IDR | 10.46% |
| 2017 | 2295.03 Billion IDR | -6.98% |
| 2016 | 2467.28 Billion IDR | -7.86% |
| 2015 | 2677.69 Billion IDR | 1.4% |
| 2014 | 2640.73 Billion IDR | 6.09% |
| 2013 | 2489.21 Billion IDR | 4.94% |
| 2012 | 2372.01 Billion IDR | 22.55% |
| 2011 | 1935.54 Billion IDR | 32.92% |
| 2010 | 1456.17 Billion IDR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 3828.43 Billion IDR | -9.36% |
| 2024 Q1 | 4595.72 Billion IDR | 25.63% |
| 2024 Q2 | 4223.61 Billion IDR | -8.1% |
| 2023 Q2 | 3749.48 Billion IDR | 2.36% |
| 2023 Q1 | 3663.12 Billion IDR | 12.2% |
| 2023 Q4 | 3658.01 Billion IDR | -0.26% |
| 2023 FY | 3658.01 Billion IDR | 12.05% |
| 2023 Q3 | 3667.73 Billion IDR | -2.18% |
| 2022 Q3 | 3206.06 Billion IDR | -7.44% |
| 2022 Q4 | 3264.73 Billion IDR | 1.83% |
| 2022 FY | 3264.73 Billion IDR | 13.24% |
| 2022 Q1 | 3633.24 Billion IDR | 26.02% |
| 2022 Q2 | 3463.8 Billion IDR | -4.66% |
| 2021 Q2 | 2754.99 Billion IDR | -2.09% |
| 2021 Q1 | 2813.7 Billion IDR | 6.09% |
| 2021 Q4 | 2882.99 Billion IDR | -7.2% |
| 2021 FY | 2882.99 Billion IDR | 8.7% |
| 2021 Q3 | 3106.55 Billion IDR | 12.76% |
| 2020 Q1 | 3350.3 Billion IDR | 30.08% |
| 2020 Q3 | 2583.78 Billion IDR | 21.18% |
| 2020 Q4 | 2652.27 Billion IDR | 2.65% |
| 2020 FY | 2652.27 Billion IDR | 2.97% |
| 2020 Q2 | 2132.13 Billion IDR | -36.36% |
| 2019 Q3 | 2346.77 Billion IDR | 11.19% |
| 2019 FY | 2575.65 Billion IDR | 1.6% |
| 2019 Q4 | 2575.65 Billion IDR | 9.75% |
| 2019 Q2 | 2110.65 Billion IDR | -24.12% |
| 2019 Q1 | 2781.59 Billion IDR | 9.72% |
| 2018 Q1 | 2225.03 Billion IDR | -3.05% |
| 2018 Q2 | 2003.76 Billion IDR | -9.94% |
| 2018 Q3 | 2496.85 Billion IDR | 24.61% |
| 2018 FY | 2535.1 Billion IDR | 10.46% |
| 2018 Q4 | 2535.1 Billion IDR | 1.53% |
| 2017 Q3 | 2226.53 Billion IDR | -9.75% |
| 2017 Q1 | 2397.64 Billion IDR | -2.82% |
| 2017 Q2 | 2467.13 Billion IDR | 2.9% |
| 2017 Q4 | 2295.03 Billion IDR | 3.08% |
| 2017 FY | 2295.03 Billion IDR | -6.98% |
| 2016 FY | 2467.28 Billion IDR | -7.86% |
| 2016 Q2 | 2741.4 Billion IDR | 3.28% |
| 2016 Q3 | 2649.14 Billion IDR | -3.37% |
| 2016 Q4 | 2467.28 Billion IDR | -6.86% |
| 2016 Q1 | 2654.25 Billion IDR | -0.88% |
| 2015 Q3 | 2534.25 Billion IDR | -6.12% |
| 2015 Q2 | 2699.38 Billion IDR | 7.22% |
| 2015 Q1 | 2517.54 Billion IDR | -4.67% |
| 2015 FY | 2677.69 Billion IDR | 1.4% |
| 2015 Q4 | 2677.69 Billion IDR | 5.66% |
| 2014 Q2 | 2649.62 Billion IDR | -1.27% |
| 2014 Q4 | 2640.73 Billion IDR | 1.12% |
| 2014 FY | 2640.73 Billion IDR | 6.09% |
| 2014 Q3 | 2611.45 Billion IDR | -1.44% |
| 2014 Q1 | 2683.63 Billion IDR | 7.81% |
| 2013 FY | 2489.21 Billion IDR | 4.94% |
| 2013 Q2 | 2607.52 Billion IDR | 3.87% |
| 2013 Q1 | 2510.38 Billion IDR | 5.83% |
| 2013 Q3 | 2544.01 Billion IDR | -2.44% |
| 2013 Q4 | 2489.21 Billion IDR | -2.15% |
| 2012 Q3 | 2006.78 Billion IDR | 0.0% |
| 2012 Q4 | 2372.01 Billion IDR | 18.2% |
| 2012 FY | 2372.01 Billion IDR | 22.55% |
| 2011 FY | 1935.54 Billion IDR | 32.92% |
| 2010 FY | 1456.17 Billion IDR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| PT Itama Ranoraya Tbk | 599.68 Billion IDR | -509.99% |
| PT Kimia Farma (Persero) Tbk | 11418.56 Billion IDR | 67.964% |
| PT Millennium Pharmacon International Tbk | 1361.96 Billion IDR | -168.583% |
| PT Soho Global Health Tbk | 2347.86 Billion IDR | -55.802% |